ENTITY
Takeda Pharmaceutical

Takeda Pharmaceutical (4502 JP)

342
Analysis
Health Care β€’ Japan
Takeda Pharmaceutical Co Ltd focuses on the Research & Development, Manufacturing, Sales and Marketing and Import/Export of Pharmaceutical Drugs. The Company focuses on the following core therapeutic areas: Cardiovascular & Metabolic, Oncology, Central Nervous System, Respiratory & Immunology, General Medicine (Gastrointestinal & Genitourinary) and Vaccine.
more
bullishβ€’Quantitative Analysis
β€’01 Jul 2026 14:20

MS-Japan Index Earning Revision (Jun): Nissan Motor, Sony Financial, Mitsui Mining & Smelting, Orix

We analyzed MS-Japan's consensus for Jun 2026 and highlighted changes of EPS in Nissan Motor, Sony Financial, Mitsui Mining & Smelting, Resonac,...

Logo
133 Views
Share
β€’19 Nov 2020 07:11

πŸ‡―πŸ‡΅ JAPAN β€’ IT’S A WRAP - Autumn 2020 Results & Revisions Review

BRIGHTER, LATER - Forecast Aggregate Net Income for the universe of Japanese listed companies ended the quarter, higher than three months ago by...

Logo
487 Views
Share
β€’30 Oct 2020 06:58

πŸ‡―πŸ‡΅ JAPAN β€’ Results & Revisions 10/​​​​​​​​​​​​​​​​​​​​29 - Fanuc, Takeda, Panasonic, Kyocera

β€’ BEST & WORST β€’ Our best and worst pair from yesterday's announcements is Fanuc (6954 JP) and Omron (6645 JP).Β  Source for all charts & tables:...

Logo
534 Views
Share
β€’21 Aug 2020 17:22

πŸ‡―πŸ‡΅ JAPAN β€’ IT’S A WRAP - Summer 2020 Results & Revisions Review

BRUTAL - The summer earnings 'season' reflected the broadening impact of COVID-19 on the Japanese and world economies, however, in terms of profit...

Logo
483 Views
Share
x